PURPOSE: This study compared the subjective quality of life (SQOL) in schizophrenia patients living with their families in Hong Kong (HK) and Beijing (BJ) and explored the relationship between SQOL and basic socio-demographic and clinical factors. MATERIALS AND METHODS: Two hundred and sixty-four clinically stable outpatients with schizophrenia were randomly selected in HK and 258 counterparts matched according to age, sex, age at onset, and length of illness in BJ. SQOL and psychiatric status were assessed with standard rating instruments. RESULTS: There was no significant difference in any of SQOL domains between the two cohorts after controlling for potentially confounding variables. Positive, depressive and anxiety symptoms and drug-induced extrapyramidal side effects (EPS) were all significantly correlated with SQOL. Multiple regression analysis revealed that only depressive symptoms predicted all SQOL domains in both groups. Having removed depressive symptoms from the model, positive symptoms predicted all domains, anxiety predicted all but social domains, use of benzodiazepines (BZD) predicted all but physical domains, EPS predicted physical domain, and history of suicide predicted social domain in HK; anxiety predicted all domains, positive symptoms predicted all but physical domains, EPS, use of BZD and history of suicide all predicted physical domains, and length of illness predicted environmental domain in BJ. CONCLUSION: Despite considerable differences between the two sites in terms of health care delivery and the economic conditions of the subjects, SQOL did not differ between HK and BJ. The conclusion is in line with previous studies that suggested that patients' SQOL was independent of their living standard as long as it reached a certain minimum level. SQOL was more strongly related to the severity of depressive symptoms and had weak association with socio-demographic factors.
PURPOSE: This study compared the subjective quality of life (SQOL) in schizophreniapatients living with their families in Hong Kong (HK) and Beijing (BJ) and explored the relationship between SQOL and basic socio-demographic and clinical factors. MATERIALS AND METHODS: Two hundred and sixty-four clinically stable outpatients with schizophrenia were randomly selected in HK and 258 counterparts matched according to age, sex, age at onset, and length of illness in BJ. SQOL and psychiatric status were assessed with standard rating instruments. RESULTS: There was no significant difference in any of SQOL domains between the two cohorts after controlling for potentially confounding variables. Positive, depressive and anxiety symptoms and drug-induced extrapyramidal side effects (EPS) were all significantly correlated with SQOL. Multiple regression analysis revealed that only depressive symptoms predicted all SQOL domains in both groups. Having removed depressive symptoms from the model, positive symptoms predicted all domains, anxiety predicted all but social domains, use of benzodiazepines (BZD) predicted all but physical domains, EPS predicted physical domain, and history of suicide predicted social domain in HK; anxiety predicted all domains, positive symptoms predicted all but physical domains, EPS, use of BZD and history of suicide all predicted physical domains, and length of illness predicted environmental domain in BJ. CONCLUSION: Despite considerable differences between the two sites in terms of health care delivery and the economic conditions of the subjects, SQOL did not differ between HK and BJ. The conclusion is in line with previous studies that suggested that patients' SQOL was independent of their living standard as long as it reached a certain minimum level. SQOL was more strongly related to the severity of depressive symptoms and had weak association with socio-demographic factors.
Authors: Kang Sim; Alex Su; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Gabor S Ungvari; Tianmei Si; Eun K Chung; Hin-Yeung Tsang; Yiong H Chan; Stephan Heckers; Naotaka Shinfuku; Chay H Tan Journal: Br J Clin Pharmacol Date: 2004-08 Impact factor: 4.335
Authors: Grace W L Chan; Gabor S Ungvari; Daniel T L Shek; John J P Leung Dagger Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2003-04 Impact factor: 4.328
Authors: P B Fitzgerald; C L Williams; N Corteling; S L Filia; K Brewer; A Adams; A R de Castella; T Rolfe; P Davey; J Kulkarni Journal: Acta Psychiatr Scand Date: 2001-05 Impact factor: 6.392
Authors: Alexander M Ponizovsky; Alexander Grinshpoon; Itzhak Levav; Michael S Ritsner Journal: Compr Psychiatry Date: 2003 Nov-Dec Impact factor: 3.735
Authors: Yu-Tao Xiang; Chuan-Yue Wang; Ying Wang; Helen F K Chiu; Jing-Ping Zhao; Qi Chen; Sandra S M Chan; Edwin H M Lee; Gabor S Ungvari Journal: Qual Life Res Date: 2010-02-05 Impact factor: 4.147
Authors: Aurigena Antunes de Araújo; Diego de Araújo Dantas; Gemma Galgani do Nascimento; Susana Barbosa Ribeiro; Katarina Melo Chaves; Vanessa de Lima Silva; Raimundo Fernandes de Araújo; Dyego Leandro Bezerra de Souza; Caroline Addison Carvalho Xavier de Medeiros Journal: Psychiatr Q Date: 2014-09
Authors: Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo Journal: Qual Life Res Date: 2011-02-03 Impact factor: 4.147
Authors: Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jacques Tremblay; Norbert Schmitz; Jean Caron Journal: Health Qual Life Outcomes Date: 2013-06-08 Impact factor: 3.186